Key regions: Brazil, India, Australia, United States, United Kingdom
The demand for antiviral drugs in Suriname has been on the rise in recent years due to the increasing prevalence of viral diseases in the country.
Customer preferences: Suriname has a high incidence of viral diseases such as dengue fever, chikungunya, and Zika virus, which has led to an increased demand for antiviral drugs. Customers in Suriname prefer antiviral drugs that are effective against multiple viral diseases, as they offer a cost-effective solution to combat the spread of these diseases.
Trends in the market: The antiviral drugs market in Suriname has been witnessing a shift towards the development of new drugs that are effective against multiple viral diseases. This trend is driven by the need to combat the spread of viral diseases that are prevalent in the country. In addition, there has been an increased focus on the development of antiviral drugs that have fewer side effects and are more affordable for customers.
Local special circumstances: Suriname is a small country located in South America that has a high incidence of viral diseases. The country has a tropical climate, which makes it a suitable breeding ground for mosquitoes that spread diseases such as dengue fever, chikungunya, and Zika virus. The prevalence of these diseases has led to an increased demand for antiviral drugs in the country.
Underlying macroeconomic factors: The antiviral drugs market in Suriname is influenced by various macroeconomic factors such as government policies, healthcare infrastructure, and economic growth. The government of Suriname has been investing in the healthcare sector, which has led to the development of better healthcare infrastructure in the country. This has increased access to healthcare services, including antiviral drugs. In addition, the country has been experiencing steady economic growth, which has resulted in an increase in disposable income and a higher demand for healthcare services.In conclusion, the antiviral drugs market in Suriname is witnessing a shift towards the development of new drugs that are effective against multiple viral diseases. This trend is driven by the high incidence of viral diseases in the country and the need to combat their spread. The government's investment in the healthcare sector and the country's steady economic growth are also contributing to the growth of the antiviral drugs market in Suriname.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
